Broker Regulation

In the midst of deep public angst over the rising cost of prescription meds, drug giant Pfizer agreed to pay roughly $785 million to put an end to a federal probe into whether it overcharged Medicaid programs for Protonix, a heartburn medication.

A state medical association is calling on similar organizations across the nation to rise up and take action against spiraling generic drug price increases.

Doomsday scenarios advanced by industry opponents of the DOL fiduciary rule are the financial services industry exaggerating the rules potential negative consequences, 2 lawmakers say.

Zenefits is under investigation by the California Department of Insurance.

President Obama is using his last budget proposal as an opportunity to strengthen the legacy of the Patient Protection and Affordable Care Act.

The Pharmaceutical Research and Manufacturers of America, the powerful trade group that represents drug companies, says it will be amping up its advertising budget to try to dissuade both voters and lawmakers from supporting restrictions.